Sanofi announced its largest-ever investment in China, committing €1 billion ($1.04 billion) to establish a new insulin production facility in the Beijing Economic and Technological Development Zone. This strategic manufacturing expansion represents a calculated response to China’s growing diabetes crisis, with recent data indicating 140 million adults living with diabetes as of 2021. The new…
What impact might a Biden administration have on drug patent law reform in China?
While the pharma industry sorts out what impact a Biden administration is likely to have on drug pricing, another consideration meaningful for the sector is the trade relations between China and the U.S. — and how they may affect drug patent law. As part of recent trade negotiations, Chinese authorities agreed to change their intellectual property…
Hackers targeted pharma and other IP for Chinese government, indictment claims
A federal grand jury in Spokane, Wash. has indicted two Chinese nationals on charges that they hacked into pharma companies and hundreds of other businesses, governments and organizations — in some cases on behalf of the Chinese Ministry of State Security. The 11-count indictment, which the U.S. Department of Justice announced today, alleges that Li…